Big Move For Calidi Biotherapeutics Inc.
Thu, Sep 21, 2023 at 07:22 PM
Calidi Biotherapeutics Inc. (CLDI:NYSEMKT) rocketted at $3.95, a gain of 27%. On Thu, Sep 21, 2023, CLDI:NYSEMKT touched a New 2-Week Intraday Low of $2.95. The stock appeared on our News Catalysts scanner on Mon, Sep 18, 2023 at 11:15 AM in the 'MERGER' category. From Thu, Sep 07, 2023, the stock recorded 22.22% Up Days and 40.00% Green Days
The stock spiked on Mon, Aug 28, 2023 at $13.79 with a volume of 1M+.
About Calidi Biotherapeutics Inc. (CLDI:NYSEMKT)
The investment seeks to provide investment results that, before fees and expenses, correspond generally to the price and yield performance of the FLAGLSX-Forensic Accounting Long-Short Index.
Top 10 Gainers:
- Digital Transformation Opportunities Corp. (DTOC:NASDAQ), 89.56%
- MSP Recovery Inc. (LIFW:NASDAQ), 54.68%
- Kaspien Holdings Inc. (KSPN:NASDAQ), 50.66%
- Near Intelligence Inc Com (NIR:NASDAQ), 40.53%
- Murphy Canyon Acquisition Corp. (MURF:NASDAQ), 32.32%
- Calidi Biotherapeutics Inc. (CLDI:NYSEMKT), 27.01%
- Vinco Ventures Inc. (BBIG:NASDAQ), 26.25%
- Powerbridge Technologies Co., Ltd. (PBTS:NASDAQ), 26.01%
- ARS Pharmaceuticals Inc Com (SPRY:NASDAQ), 25.68%
- TradeUP Acquisition Corp. (UPTD:NASDAQ), 24.73%